IAC/Interactivecorp vs Revvity Inc — how do they compare? IAC/Interactivecorp trades at $43.41 (market cap $3.28B), while Revvity Inc trades at $110.67 (market cap $12.33B). The key difference: Revvity Inc is far larger — about 3.8× IAC/Interactivecorp's market cap, and Revvity Inc pays a 0.25% dividend while IAC/Interactivecorp pays none. Which is the better fit depends on your goals.
| PPLI | RVTY | |
|---|---|---|
Market Cap | $3.28B | $12.33B |
Sector | Media | Technology |
52-Week High | $47.62 | $117.75 |
52-Week Low | $31.52 | $82.26 |
Enterprise Value | $3.58B | $14.82B |
Dividend Yield | — | 0.25% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
RVTY trades at $106.44, down 3.37% today, with a bullish technical outlook despite near-term weakness. The company maintains stable revenue around $2.9B with consistent earnings beats, though valuation multiples appear elevated with a P/E of 51. Recent AI product launches and FDA clearances demonstrate innovation in life sciences and diagnostics. Analyst consensus remains positive with a $111.43 price target and no sell ratings among 29 covering firms.
The stock presents a growth opportunity with strong analyst support and technological innovation, but faces risks from margin pressure and China market exposure. Current levels near support at $105 offer potential entry, though the high P/E requires sustained earnings growth to justify valuation. Upcoming Q2 earnings on August 4, 2026 will be critical for near-term direction.
Trailing returns across standard periods
IAC Inc is an Internet media company with segments that include Angi (47% of total revenue), Dotdash (10%), search (24%), and emerging and other (19%). The firm spun off the narrow-moat dating app provider Match Group in second-quarter 2020 and the no-moat video software provider Vimeo in second-quarter 2021.
Read more on PPLI →Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →